What’s Broken in Freight Tech Right Now?

The freight tech landscape is experiencing challenges as new factors begin to impact operations. Metafora's Ryan Schreiber and Transflo's Don Everhart discuss the current issues and potential solutions. One significant development is the emergence of GLP-1 medications, like Ozempic and Mounjaro, which are affecting freight volumes.

FreightWaves estimates a 2% reduction in food and beverage shipments, translating to around 2 million truckloads annually out of 100 million food and beverage moves. This reduction is primarily due to dietary changes and behavioral shifts among consumers, as reflected in Walmart data. Men using GLP-1 medications show 10% fewer calorie purchases, while women show 6% to 8% fewer.

The snack food and beverage category is particularly affected, with softer-than-expected summer volumes potentially signaling a trend. Additionally, the impact of GLP-1 drugs extends beyond diet, with participants discussing broader health benefits, including reduced alcohol consumption and potential applications in Alzheimer's, kidney disease, and ADHD.

While only about 10% of the U.S. population uses GLP-1 medications, skepticism and vanity could limit wider adoption. The freight industry must consider these changing patterns and prepare for potential demand destruction in affected freight lanes.